View details of this raise on Seedstage

Las Vegas, NV

Delivering affordable self-tuned clinical grade hearing aids to improve global accessibility.

• Global problem: Targets 1.5 billion people worldwide affected by hearing loss.
• Patented system: Proprietary tuning process allows users to program devices at home in minutes.
• Affordable access: Low monthly subscription with included device replacement.
• Proven development: Completed clinical trials, FDA-certified devices, and four issued patents.
• Large market potential: Positioned to serve underserved global markets where audiologists are scarce.

Doppler Labs is raising funds to make hearing aids more accessible and affordable through its patented system that allows users to tune their own devices at home in minutes rather than months. Traditional hearing aid solutions require multiple costly visits to an audiologist, often leading to poor adoption and unused devices. By combining FDA-certified clinical grade hearing aids with an intuitive software-driven process, Doppler Labs enables users to create customized hearing profiles across multiple environments such as restaurants, workplaces, and social events. This approach not only lowers costs but also provides convenience, flexibility, and greater satisfaction for individuals with mild to moderate hearing loss.

The fundraising will support production, engineering, marketing, and final validation as the company moves from beta into commercialization. With over 1.5 billion people worldwide affected by hearing loss—most of whom live in countries with limited audiologist access—Doppler Labs is targeting both underserved international markets and the large U.S. market. Its subscription-based model, which includes device replacement and ongoing support, positions the company for recurring revenue and scalability. Backed by issued patents, a clean cap table, and completed clinical trials, Doppler Labs is building a global solution to address one of the most significant unmet healthcare needs.

Company Info

Doppler Labs provides an at-home system for tuning FDA-certified hearing aids, offering affordable and accessible hearing care worldwide.

Doppler Labs is a hearing technology company developing a patented system that allows users to tune their own FDA-certified hearing aids at home in as little as 5–10 minutes. The system includes a tablet-based tuning assistant named Jenn, which guides users through short conversational prompts to personalize audio quality. This approach eliminates the traditional need for multiple audiologist visits, reducing cost and improving accessibility for people with mild to moderate hearing loss.

The company’s model combines clinical-grade, rechargeable, Bluetooth-enabled hearing aids with a low monthly subscription that includes device replacement and support. With more than 1.5 billion people worldwide experiencing hearing loss, and limited audiologist availability in many regions, Doppler Labs is positioned to reach underserved markets in both the US and abroad. Its multi-channel distribution strategy includes direct-to-consumer, retail, and international partnerships, with the goal of making high-quality hearing solutions affordable and widely accessible.